Sarosdy MF - Search Results

1

In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.

Sarosdy MF, Higdon AL, Demoor CA. Sarosdy MF, et al. J Urol. 1996 Jun;155(6):2085-9. J Urol. 1996. PMID: 8618341

2

Oral bropirimine immunotherapy of rodent prostate cancer.

Sarosdy MF. Sarosdy MF. Eur Urol. 1997;31 Suppl 1:5-9. doi: 10.1159/000474525. Eur Urol. 1997. PMID: 9076480

3

Phase 1 trial of oral bropirimine in superficial bladder cancer.

Sarosdy MF, Lamm DL, Williams RD, Moon TD, Flanigan RC, Crawford ED, Wilks NE, Earhart RH, Merritt JA. Sarosdy MF, et al. J Urol. 1992 Jan;147(1):31-3. doi: 10.1016/s0022-5347(17)37126-4. J Urol. 1992. PMID: 1729546

4

Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial.

Sarosdy MF, Lowe BA, Schellhammer PF, Lamm DL, Graham SD Jr, Grossman HB, See WA, Peabody JO, Moon TD, Flanigan RC, Crawford ED, Morganroth J. Sarosdy MF, et al. Urology. 1996 Jul;48(1):21-7. doi: 10.1016/s0090-4295(96)90059-x. Urology. 1996. PMID: 8693646 Clinical Trial.

5

Bropirimine immunotherapy of upper urinary tract carcinoma in situ.

Sarosdy MF, Pisters LL, Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, Lerner SP, Koch MO, Schellhammer PF. Sarosdy MF, et al. Urology. 1996 Jul;48(1):28-32. doi: 10.1016/s0090-4295(96)00080-5. Urology. 1996. PMID: 8693647 Clinical Trial.

6

Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin.

Sarosdy MF, Manyak MJ, Sagalowsky AI, Belldegrun A, Benson MC, Bihrle W, Carroll PR, Ellis WJ, Hudson MA, Sharkey FE. Sarosdy MF, et al. Urology. 1998 Feb;51(2):226-31. doi: 10.1016/s0090-4295(97)00510-4. Urology. 1998. PMID: 9495702 Clinical Trial.

7

A review of clinical studies of bropirimine immunotherapy of carcinoma in situ of the bladder and upper urinary tract.

Sarosdy MF. Sarosdy MF. Eur Urol. 1997;31 Suppl 1:20-6. doi: 10.1159/000474527. Eur Urol. 1997. PMID: 9076482 Review.

8

Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone.

Sarosdy MF, Kierum CA. Sarosdy MF, et al. J Urol. 1989 Nov;142(5):1376-9. doi: 10.1016/s0022-5347(17)39103-6. J Urol. 1989. PMID: 2810534

9

Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.

Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M. Pastuszak AW, et al. Among authors: sarosdy mf. J Urol. 2015 Nov;194(5):1271-6. doi: 10.1016/j.juro.2015.05.084. Epub 2015 May 27. J Urol. 2015. PMID: 26025500

10

Correlation of clonogenic growth with histologic diagnosis after resection of residual tissue following chemotherapy for nonseminomatous testis cancer.

Sarosdy MF, Einhorn LH, Donohue JP, Von Hoff DD. Sarosdy MF, et al. Urology. 1989 Dec;34(6):396-8. doi: 10.1016/0090-4295(89)90452-4. Urology. 1989. PMID: 2556829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters